The Trump administration is reportedly set to announce tariffs as soon as Thursday on drugmakers that have not struck deals guaranteeing low U.S. prices, according to Bloomberg. This raises regulatory and political risk for large pharma, likely to pressure sector equities and increase volatility pending the formal announcement and the list of targeted companies.
The Trump administration is reportedly set to announce tariffs as soon as Thursday on drugmakers that have not struck deals guaranteeing low U.S. prices, according to Bloomberg. This raises regulatory and political risk for large pharma, likely to pressure sector equities and increase volatility pending the formal announcement and the list of targeted companies.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
